Learning Center
Plans & pricing Sign in
Sign Out

2013 | || Diabetic Peripheral Neuropathy – Pipeline Review, H2 2012


									You can also request for sample page of above
mention reports on
Price :
$ 2000 - PDF | $ 4000 - Site Licence | $ 6000 - Corporate Licence

Pages : 43

Global Markets Direct’s, Diabetic Peripheral Neuropathy - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Diabetic Peripheral
Neuropathy, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Diabetic Peripheral Neuropathy. Diabetic Peripheral
Neuropathy - Pipeline Review, Half Year is built using data and information
sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

- A snapshot of the global therapeutic scenario for Diabetic Peripheral
 - A review of the Diabetic Peripheral Neuropathy products under development by
companies and universities/research institutes based on information derived
from company and industry-specific sources.
 - Coverage of products based on various stages of development ranging from
discovery till registration stages.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Diabetic Peripheral Neuropathy.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
Table Of Contents

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Diabetic Peripheral Neuropathy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Diabetic Peripheral Neuropathy 7
Diabetic Peripheral Neuropathy Therapeutics under Development by
Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Diabetic Peripheral Neuropathy Therapeutics – Products under Development
by Companies 12
Companies Involved in Diabetic Peripheral Neuropathy Therapeutics
Development 13…………………
More Related Reports:

Primitive Neuroectodermal Tumor (PNET) – Pipeline Review, H2 2012

Post-Operative Pain – Pipeline Review, H2 2012

Acute Promyelocytic Leukemia – Pipeline Review, H2 2012

Wet (Neovascular / Exudative) Macular Degeneration – Pipeline
Review, H2 2012

Left Ventricular Dysfunction – Pipeline Review, H2 2012
For More details about above & other Reports
plz contact :


Contact: Marketing team

To top